Volume 29, Number 1—January 2023
Online Report
Efficiency of Field Laboratories for Ebola Virus Disease Outbreak during Chronic Insecurity, Eastern Democratic Republic of the Congo, 2018–2020
Table 1
Type of setup, activities, and sites in field laboratories for EVD outbreak, eastern Democratic Republic of the Congo, 2018–2020*
Type of laboratory setup | Activities performed | Sites/provinces |
---|---|---|
Basic |
EVD diagnosis: GeneXpert (+)†; Chemistry: Piccolo (+/–)‡ |
Tchomia/Ituri, Bunia/Ituri, Tchowe/South-Kivu Bukavu/South-Kivu, Biakato/Ituri, Kasindi/North-Kivu |
Standard§ |
EVD diagnosis: GeneXpert (+); Chemistry: Piccolo (+); Hematology: pocH-100i (+)¶; Ebola survivors clinic |
Mangina/North-Kivu, Goma/North-Kivu, Komanda/Ituri, Mambasa/Ituri |
Advanced§ | EVD diagnosis: GeneXpert (+); Chemistry: Piccolo (+); Hematology: pocH-100i; Ebola survivors clinic; EVD differential diagnosis (Smart cycler or RPA) (+) or genomic sequencing (+) |
Beni/North-Kivu, Butembo/North-Kivu, Katwa/North-Kivu |
*EVD, Ebola virus disease; RPA, recombinase polymerase amplification. †GeneXpert, (Cepheid, https://www.cepheid.com). ‡Abaxis (https://www.abaxis.com). §Sysmex (https://www.sysmex.com). ¶Research support: Ebola therapeutics through a Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) protocol or the Pamoja Tulinde Maisha/Together save lives (PALM) randomized controlled trial; the immunogenicity of rVSV-ZEBOV-GP vaccine; and the study of Ebola virus reservoir in bats.